Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARS Pharmaceuticals
Pharma
ARS hits major setback in bid to launch epinephrine newcomer
The company had already aligned with the FDA in August on final labeling and a post-marketing study plan. Now, it's appealing the FDA rejection.
Fraiser Kansteiner
Sep 20, 2023 10:31am
FDA accepts ARS' filing for nasal spray EpiPen rival for review
Oct 25, 2022 10:27am
ARS inks reverse merger to get epinephrine nasal spray to market
Jul 26, 2022 10:22am
Meet Neffy, the kid-friendly epinephrine nasal spray from ARS
Sep 3, 2021 11:27am